221 related articles for article (PubMed ID: 15221866)
1. Flow cytometric test for beryllium sensitivity.
Milovanova TN; Popma SH; Cherian S; Moore JS; Rossman MD
Cytometry B Clin Cytom; 2004 Jul; 60(1):23-30. PubMed ID: 15221866
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
Milovanova TN
Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Candida-specific blastogenesis: comparison of carboxyfluorescein succinimidyl ester labelling of T cells, thymidine incorporation, and CD69 expression.
Angulo R; Fulcher DA
Cytometry; 1998 Jun; 34(3):143-51. PubMed ID: 9696158
[TBL] [Abstract][Full Text] [Related]
4. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
5. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
Stange AW; Furman FJ; Hilmas DE
Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cell replication by bovine T cells in polyclonally activated cultures using carboxyfluorescein succinimidyl ester (CFSE) loading and flow cytometric analysis.
Sathiyaseelan T; Baldwin CL
Res Vet Sci; 2000 Dec; 69(3):275-81. PubMed ID: 11124100
[TBL] [Abstract][Full Text] [Related]
7. [Development of a CFSE-based flow cytometry for evaluating EIAV-stimulated proliferation of T lymphocytes].
Lin YZ; Deng XL; Shen N; Lü XL; Zhao LP; Kong XG; Shao YM; Zhou JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1044-7. PubMed ID: 18992187
[TBL] [Abstract][Full Text] [Related]
8. Tracking cell proliferation using the far red fluorescent dye SNARF-1.
Magg T; Albert MH
Cytometry B Clin Cytom; 2007 Nov; 72(6):458-64. PubMed ID: 17397063
[TBL] [Abstract][Full Text] [Related]
9. Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPT.
Farris GM; Newman LS; Frome EL; Shou Y; Barker E; Habbersett RC; Maier L; Smith HN; Marrone BL
Toxicology; 2000 Feb; 143(2):125-40. PubMed ID: 10755700
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
Fontenot AP; Maier LA
Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of lymphoproliferative responses by carboxy fluorescein succinimidyl ester assay in heart recipients with infections.
Valor L; Sarmiento E; Navarro J; Gallego A; Fernandez-Yañez J; Fernandez-Cruz E; Carbone J
Transplant Proc; 2012 Nov; 44(9):2649-52. PubMed ID: 23146483
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
13. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
14. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling.
Hu H; Dong Y; Feng P; Fechner J; Hamawy M; Knechtle SJ
Transplantation; 2003 Apr; 75(7):1075-7. PubMed ID: 12698107
[TBL] [Abstract][Full Text] [Related]
16. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
[TBL] [Abstract][Full Text] [Related]
17. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
18. Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions.
Abate G; Eslick J; Newman FK; Frey SE; Belshe RB; Monath TP; Hoft DF
J Infect Dis; 2005 Oct; 192(8):1362-71. PubMed ID: 16170753
[TBL] [Abstract][Full Text] [Related]
19. Chronic beryllium disease: a hypersensitivity disorder.
Rossman MD
Appl Occup Environ Hyg; 2001 May; 16(5):615-8. PubMed ID: 11370939
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
